Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3990578)

Published in PLoS One on April 17, 2014

Authors

Lukas E Dow1, Zeina Nasr2, Michael Saborowski1, Saya H Ebbesen3, Eusebio Manchado1, Nilgun Tasdemir3, Teresa Lee2, Jerry Pelletier4, Scott W Lowe5

Author Affiliations

1: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
2: Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
3: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America.
4: Department of Biochemistry, McGill University, Montreal, Quebec, Canada; The Rosalind and Morris Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada.
5: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

Articles cited by this

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev (2001) 15.97

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell (2003) 15.43

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell (1988) 7.50

Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A (2000) 5.99

Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc (2009) 4.50

A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun (1997) 4.47

Far-red fluorescent tags for protein imaging in living tissues. Biochem J (2009) 4.38

Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res (2005) 4.08

A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell (2011) 3.69

An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev (2011) 2.38

Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem (2004) 2.06

A pipeline for the generation of shRNA transgenic mice. Nat Protoc (2012) 1.76

Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. Proc Natl Acad Sci U S A (2005) 1.35

Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology. Neurobiol Dis (2007) 1.23

Life in the fast lane: mammalian disease models in the genomics era. Cell (2012) 1.08

A modular and flexible ESC-based mouse model of pancreatic cancer. Genes Dev (2014) 0.99

Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic mice. PLoS One (2013) 0.96

Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models. Bioessays (2011) 0.89